Rchr
J-GLOBAL ID：201301004098925925
Update date: Sep. 16, 2022
Azuma Masahiro
Azuma Masahiro
Contact this researcher
You can send email directly to the researcher.
Affiliation and department：
Nippon Medical School
About Nippon Medical School
Search "Nippon Medical School"
Research field (1)：
Immunology
Papers (7)：
Tsukasa Seya, Hiroaki Shime, Hiromi Takaki, Masahiro Azuma, Hiroyuki Oshiumi, Misako Matsumoto. TLR3/TICAM-1 signaling in tumor cell RIP3-dependent necroptosis. ONCOIMMUNOLOGY. 2012. 1. 6. 917-923
Masahiro Azuma, Takashi Ebihara, Hiroyuki Oshiumi, Misako Matsumoto, Tsukasa Seya. Cross-priming for antitumor CTL induced by soluble Ag plus polyI:C depends on the TICAM-1 pathway in mouse CD11c(+)/CD8 alpha(+) dendritic cells. ONCOIMMUNOLOGY. 2012. 1. 5. 581-592
Tsukasa Seya, Jun Kasamatsu, Masahiro Azuma, Hiroaki Shime, Misako Matsumoto. Natural Killer Cell Activation Secondary to Innate Pattern Sensing. JOURNAL OF INNATE IMMUNITY. 2011. 3. 3. 264-273
Takashi Ebihara, Masahiro Azuma, Hiroyuki Oshiumi, Jun Kasamatsu, Kazuya Iwabuchi, Kenji Matsumoto, Hirohisa Saito, Tadatsugu Taniguchi, Misako Matsumoto, Tsukasa Seya. Identification of a polyI:C-inducible membrane protein that participates in dendritic cell-mediated natural killer cell activation. JOURNAL OF EXPERIMENTAL MEDICINE. 2010. 207. 12. 2675-2687
Masahiro Azuma, Ryoko Sawahata, Yuusuke Akao, Takashi Ebihara, Sayuri Yamazaki, Misako Matsumoto, Masahito Hashimoto, Koichi Fukase, Yukari Fujimoto, Tsukasa Seya. The Peptide Sequence of Diacyl Lipopeptides Determines Dendritic Cell TLR2-Mediated NK Activation. PLOS ONE. 2010. 5. 9
ｍore...
MISC (2)：
Regulation of cross-presentation by TLR signaling. Clinical immunology & allergology. 2010. 54. 5. 527-534
東 正大, 松尾 綾, 松本 美佐子. Lipid A誘導体におけるTLR4依存性細胞応答 (第16回 天然薬物の開発と応用シンポジウム講演要旨集). 薬学雑誌. 2006. 126. 0. 166-169
Work history (1)：
Hokkaido University Graduate School of Medicine
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in
researchmap
.
For details, see here
.
Return to Previous Page
TOP
BOTTOM
